Liver Cancer

Oncology Solutions

Liver cancer is the fifth most common cancer, accounting for 8.2 percent of all cancer deaths worldwide.1 The incidence is rising across all continents including in the United States. A study published in JAMA Oncology, December 2017 found the incidence of liver cancer increased by 75 percent worldwide between 1990 and 2015.2 Effective surveillance programs with imaging could offer early diagnosis and provide an opportunity for better treatment options.

The Patient Journey

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...

The latest in Oncology


INSIGHTS
1. IARC database of 2018.
2. JAMA Oncol. 2017;3(12):1683-1691. doi:10.1001/jamaoncol.2017.3055Published online October 5, 2017. Corrected on December 14, 2017.

JB00324AFG